ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 620277 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 620277; 2) Community: the network communities that were significantly associated with the response to NSC 620277; 3) Molecule: the relationships between components within communities and NSC 620277; 4) MDR: the compounds that were significantly associated with the NSC 620277.

NSC Compound Enrichment Correlation
NSC 755263 Null 0.0287337488682932 0.26818844
NSC 756193 GSK978744A 0.0287337488682932 0.18886083
NSC 756998 1-[(4-aminophenyl)-(4-hydroxyphenyl)methylidene]-[3]ferrocenophane 0.0287337488682932 -0.012602861
NSC 78312 Null 0.0287337488682932 0.31571889
NSC 88971 Null 0.0287337488682932 0.18765504
NSC 95779 Null 0.0287337488682932 0.22413567
NSC 107124 Camptothecin Derivative 0.0312262198176281 -0.020318553
NSC 128687 6H-Furo[2',3':4,5]oxazolo[3,2-a]pyrimidine-2-methanol, 2,3,3a,9a-tetrahydro-6-imino-3-(phosphonooxy)-, (2R-(2.alpha.,3.beta.,3a.beta.,9a.beta.))- (9CI) 0.0312262198176281 0.24690811
NSC 175490 Iron, carbonyl(.eta.5-2,4-cyclopentadien-1-yl)(di-4-morpholinylcarbamodithioato-S,S')- 0.0312262198176281 0.18279432
NSC 179074 Lead, bis[(2-cyanoethyl)cyclohexylcarbamodithioato-S,S']-, (T-4)- 0.0312262198176281 0.27872264
Total:139  Current:100    [First] [Prev] [Next] [Last]